维普中文期刊产品整合服务
25篇 您的检索式:作者名="Kaplenko"
    题名 作者 年代 出处 被引量
1Unfavorable prognosticvalue of CD24 expression in sections from primary and relapsed o-varian cancer tissue显示文摘Surowiak P Matema V Kaplenko I 2006Int J Gynecol Cancer2006,16,2:1
2Topoisomerase 1A, HER/ 2neu and Ki67 expression in paired primary and relapse ovarian cancer tissue samples显示文摘Surowiak P Materna V Kaplenko I 2006J Histopathol2006,21,7:1
3ABCC2 (MRP2, cMOAT) can be localized in the nuclearmembrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome显示文摘Surowiak P Matema V Kaplenko I 2006Clin Cancer Res2006,12,23:1
4Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue显示文摘Surowiak P Matema V Kaplenko 1 2006Int J Gynecol Cancer2006,16,2:1
5Topoisomerase l A, HER2/neu and Ki67 expression in paired primary and relapse ovarian cancer tissue samples显示文摘SUROWIAK P MATERNA V KAPLENKO 1 2006Histopathol2006,21,7:1
6Topoisomerase 1A, HER-2/neu and Ki67 expression in paired primary and re- lapse ovarian cancer tissue samples显示文摘Surowiak P Materna V Kaplenko I 2006Histopathol2006,21,7:1
7Unfavorable prognostic value of CD24 expressionin sections from primary and relapsed ovariancancer tissue 显示文摘Syrowiaks P Matema V Kaplenko I 2006Int J Gynecol Cancer2006,16,2:1
8Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients显示文摘Surowiak P Materna V Kaplenko I 2005Virchows Arch2005,447,62:1
9Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue显示文摘Surowiak P Materna V Kaplenko I 0,,2:1
10Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue显示文摘P. SUROWIAK V. MATERNA I. KAPLENKO M. SPACZY?SKI M. DIETEL G. KRISTIANSEN H. LAGE M. ZABEL 2006International Journal of Gynecological Cancer2006,,2:1
11Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue显示文摘Surowiak P Matema V Kaplenko I 2006Int J Gynecol Cancer2006,16,2:1
12ABCC2 (MRP2,cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome 显示文摘Surowiak P Matema V Kaplenko I 2006Clin Cancer Res2006,12,23:1
13Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue显示文摘Surowiak P Materna V Kaplenko I 2006Int J Gynecol Cancer2006,16,2:1
14ABCC2 (MRF2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome显示文摘SUROWIAK P MATERNA V KAPLENKO I 2006CAin Cancer Res2006,12,17:1
15Unfavorable prognostic value of CD2g expression in sections from primary and relapsed ovarian cancer tissue 显示文摘Surowiak P Materna V Kaplenko I 2006Int J Gynecol Cancer2006,16,2:1
16Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients显示文摘Surowiak P Materna V Kaplenko I 0,,3:1
17Augmented expression of met- allothionein and glutathione S - transferase pi as unfavourable prognostic factors in cisplatin - treated ovarian cancer patients 显示文摘Surowiak P Materna V Kaplenko I 2005Virehows Arch2005,447,3:1
18Taxol-resistance-associatod gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients显示文摘 Surowiak P Kaplenko I 2007Virehows Arch2007,450,2:1
19Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients显示文摘Surowiak P Materna V Kaplenko I 2005Virchows Arch2005,447,3:1
20ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome 显示文摘Surowiak P Materna V Kaplenko I 2006Clin Cancer Res2006,12,23:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费